Mark Hsiao, MD
Orthopaedic Surgery of the Spine · Alhambra, CANPI 1114008984
Payments from drug & device makers
Across 64 payments — averaging $281.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- Synthes GmbH$1K
- Goode Surgical Inc$1K
- Stryker$758
- Si-bone, Inc.$534
- Abbott$497
- plus $1K from 11 others
What the payments were for
- Grants$10,00055%
- Travel & lodging$3,71021%
- Food & beverage$1,92311%
- Education$2,40013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $12,132 |
| Synthes GmbH | 2 | $1,487 |
| Goode Surgical Inc | 7 | $1,391 |
| Stryker | 11 | $758 |
| Si-bone, Inc. | 5 | $534 |
| Abbott | 3 | $497 |
| Medtronic | 2 | $270 |
| Boston Scientific | 7 | $237 |
| Clariance, Inc. | 2 | $175 |
| Zimmer Biomet | 1 | $135 |
| Saxum Surgical, Inc. | 1 | $125 |
| Amgen | 1 | $121 |
| Johnson & Johnson | 2 | $81 |
| AbbVie(2 entities) | 3 | $48 |
| KCI USA, Inc. | 1 | $19 |
| Lifenet Health | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$488
- IFUSE IMPLANT SYSTEM$447
- INBONE$404
- STEALTH AUTOGUIDE SYSTEM$162
- WaveWriter Alpha Prime 16$147
- Avenir$135
- Erisma-LP$127
- Idys-TLIF 3DTi$127
- EVENITY$121
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$108
- PROstep$104
How this compares
$18,033 in reported general payments places this provider in the 45th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 447 | $12,160 |
| Gabapentin | 385 | $2,700 |
| Meloxicam | 173 | $1,093 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $350 |
| Ondansetron Hcl | 29 | $167 |
| Tramadol Hcl | 20 | $128 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Alhambra
- Hyun BaeSanta Monica$62.2M
- Choll KimSan Diego$4M
- Stacey BedermanOrange$3.7M
- Gregory Mundisla Jolla$3.5M
- Neelakantan AnandLos Angeles$3.2M
- Paul SlosarDaly City$3.1M
- Babak Barcohanavan Nuys$2.9M
- Rick DelamarterSanta Monica$2.3M
- Sanjay KhuranaMarina del Rey$2.3M
- Neville AlleyneOceanside$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.